You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Arzerra

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphoma Trial in Houston (Ofatumumab)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)

Recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Xi'an, Shaanxi, China
    Tangdu Hospital
Aug 16, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023

Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

Active, not recruiting
Has Results
  • Small Lymphocytic Lymphoma
  • CLL (Chronic Lymphocytic Leukemia)
  • Fludarabine Phosphate
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Chronic Lymphocytic Leukemia Trial in Spain (Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Badalona, Spain
  • +8 more
May 2, 2022

Oncology Patients Receiving Chemo Trial in United States (Cetirizine HCl 10 mg/mL, Diphenhydramine 50 mg/mL, anti-CD20 such as

Completed
Has Results
  • Oncology Patients Receiving Chemotherapy
  • Cetirizine HCl 10 mg/mL
  • +2 more
  • Napa, California
  • +6 more
Apr 25, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 2, 2021

Diffuse Large B Cell Lymphoma Trial in Poland (Ofatumumab, Etoposide, Ifosfamid)

Completed
  • Diffuse Large B Cell Lymphoma
  • Wrocław, Dolnośląskie, Poland
  • +7 more
Dec 23, 2021

Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
Has Results
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • alemtuzumab
  • +2 more
  • Chicago, Illinois
  • +1 more
Dec 29, 2020

Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

Completed
  • Follicular Lymphoma, Grade 1
  • +2 more
  • Alessandria, AL, Italy
  • +26 more
Jun 16, 2022

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Placebo)

Terminated
  • Nephrotic Syndrome
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Rituximab)

Completed
  • Nephrotic Syndrome
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Chronic Lymphocytic Leukemia (CLL) Trial in Toronto (Ofatumumab with GSK2110183)

Completed
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Ofatumumab with GSK2110183
  • Toronto, Ontario, Canada
    University Health Network-Princess Margaret Hospital
Sep 20, 2019

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
Has Results
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +68 more
Mar 15, 2021

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia

Terminated
Has Results
  • Acute Lymphoblastic Leukemia in Remission
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 18, 2021

Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 16, 2019